The promise and progress of RNA-interference-based antiviral therapy for respiratory syncytial virus.

The promise and progress of RNA-interference-based antiviral therapy for respiratory syncytial virus.

Respiratory syncytial virus (RSV) is a major cause of morbidity in infants, young children, and the elderly worldwide. Presently, there are no explicit recommendations for RSV treatment apart from supportive care. Recent progress in studies of the mechanism of RNA interference suggests the formation...

Full description

Bibliographic Details
Main Authors: V. V. Vysochinskayа, E. V. Esaulenko, A. A. Bogdanov, D. N. Ghorab, N. A. Кnyazev, M. V. Dubina
Format: Article
Language:Russian
Published: Journal Infectology 2014-09-01
Series:Žurnal Infektologii
Subjects:
respiratory syncytial virus
small interfering rna
rna interference
Online Access:https://journal.niidi.ru/jofin/article/view/126
id doaj-333bfbc6304b41ff873a092dfbab5954
record_format Article
spelling doaj-333bfbc6304b41ff873a092dfbab59542021-08-02T08:43:17ZrusJournal InfectologyŽurnal Infektologii 2072-67322014-09-014451210.22625/2072-6732-2012-4-4-5-12140The promise and progress of RNA-interference-based antiviral therapy for respiratory syncytial virus.V. V. Vysochinskayа0E. V. Esaulenko1A. A. Bogdanov2D. N. Ghorab3N. A. Кnyazev4M. V. Dubina5Science Research Institute of Influenza, Saint-PetersburgScience Research Institute of Influenza, Saint-PetersburgSaint-Petersburg Academic University – Physics and Technology Research and Education Center of Nanotechnologies of Russian Academy of Sciences, Saint-PetersburgSaint-Petersburg Academic University – Physics and Technology Research and Education Center of Nanotechnologies of Russian Academy of Sciences, Saint-PetersburgSaint-Petersburg Academic University – Physics and Technology Research and Education Center of Nanotechnologies of Russian Academy of Sciences, Saint-PetersburgSaint-Petersburg Academic University – Physics and Technology Research and Education Center of Nanotechnologies of Russian Academy of Sciences, Saint-PetersburgRespiratory syncytial virus (RSV) is a major cause of morbidity in infants, young children, and the elderly worldwide. Presently, there are no explicit recommendations for RSV treatment apart from supportive care. Recent progress in studies of the mechanism of RNA interference suggests the formation of a new class of antiviral drugs in the treatment of RSV infection and related respiratory diseases.https://journal.niidi.ru/jofin/article/view/126respiratory syncytial virussmall interfering rnarna interference
collection DOAJ
language Russian
format Article
sources DOAJ
author V. V. Vysochinskayа
E. V. Esaulenko
A. A. Bogdanov
D. N. Ghorab
N. A. Кnyazev
M. V. Dubina
spellingShingle V. V. Vysochinskayа
E. V. Esaulenko
A. A. Bogdanov
D. N. Ghorab
N. A. Кnyazev
M. V. Dubina
The promise and progress of RNA-interference-based antiviral therapy for respiratory syncytial virus.
Žurnal Infektologii
respiratory syncytial virus
small interfering rna
rna interference
author_facet V. V. Vysochinskayа
E. V. Esaulenko
A. A. Bogdanov
D. N. Ghorab
N. A. Кnyazev
M. V. Dubina
author_sort V. V. Vysochinskayа
title The promise and progress of RNA-interference-based antiviral therapy for respiratory syncytial virus.
title_short The promise and progress of RNA-interference-based antiviral therapy for respiratory syncytial virus.
title_full The promise and progress of RNA-interference-based antiviral therapy for respiratory syncytial virus.
title_fullStr The promise and progress of RNA-interference-based antiviral therapy for respiratory syncytial virus.
title_full_unstemmed The promise and progress of RNA-interference-based antiviral therapy for respiratory syncytial virus.
title_sort promise and progress of rna-interference-based antiviral therapy for respiratory syncytial virus.
publisher Journal Infectology
series Žurnal Infektologii
issn 2072-6732
publishDate 2014-09-01
description Respiratory syncytial virus (RSV) is a major cause of morbidity in infants, young children, and the elderly worldwide. Presently, there are no explicit recommendations for RSV treatment apart from supportive care. Recent progress in studies of the mechanism of RNA interference suggests the formation of a new class of antiviral drugs in the treatment of RSV infection and related respiratory diseases.
topic respiratory syncytial virus
small interfering rna
rna interference
url https://journal.niidi.ru/jofin/article/view/126
work_keys_str_mv AT vvvysochinskaya thepromiseandprogressofrnainterferencebasedantiviraltherapyforrespiratorysyncytialvirus
AT evesaulenko thepromiseandprogressofrnainterferencebasedantiviraltherapyforrespiratorysyncytialvirus
AT aabogdanov thepromiseandprogressofrnainterferencebasedantiviraltherapyforrespiratorysyncytialvirus
AT dnghorab thepromiseandprogressofrnainterferencebasedantiviraltherapyforrespiratorysyncytialvirus
AT naknyazev thepromiseandprogressofrnainterferencebasedantiviraltherapyforrespiratorysyncytialvirus
AT mvdubina thepromiseandprogressofrnainterferencebasedantiviraltherapyforrespiratorysyncytialvirus
AT vvvysochinskaya promiseandprogressofrnainterferencebasedantiviraltherapyforrespiratorysyncytialvirus
AT evesaulenko promiseandprogressofrnainterferencebasedantiviraltherapyforrespiratorysyncytialvirus
AT aabogdanov promiseandprogressofrnainterferencebasedantiviraltherapyforrespiratorysyncytialvirus
AT dnghorab promiseandprogressofrnainterferencebasedantiviraltherapyforrespiratorysyncytialvirus
AT naknyazev promiseandprogressofrnainterferencebasedantiviraltherapyforrespiratorysyncytialvirus
AT mvdubina promiseandprogressofrnainterferencebasedantiviraltherapyforrespiratorysyncytialvirus
_version_ 1721237523718471680

Similar Items